No Evidence for Effective Prevention of Venous Thromboembolism With Low-Molecular-Weight Heparin After Anterior Cruciate Ligament Reconstruction: Response.

The authors convey their response to a feedback about their report on low-molecular-weight heparin (LMWH) for the prevention of venous thromboembolism in patients undergoing knee arthroscopic surgery and anterior cruciate ligament reconstruction (ACLR). Topics mentioned include heterogeneity of surgical interventions in the ACLR subgroup, knee arthroscopy surgery with simple procedures without ligament reconstruction, and risk-benefit balance for prophylaxis with LMWH.